A health insurance issuer shall periodically review its prior authorization requirements and consider removal of prior authorization requirements:
- (1) where a medication or procedure prescribed is customary and properly indicated or is a treatment for the clinical indication as supported by peer-reviewed medical publications; or
- (2) for patients currently managed with an established treatment regimen.
(Source: P.A. 102-409, eff. 1-1-22.)